The Dry Eye Zone

Dry Eye Drugs

Dry eye drugs currently on the market.

Dry Eye Drugs

This is a list of drugs of drugs approved for sale in the indicated countries.
Please
contact us with corrections or additions.


USA

FDA-approved drugs for dry eye or related conditions

CEQUA (2018)
Cyclosporine ophthalmic solution 0.09%
Sun Pharmaceuticals.
Indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye).

OXERVATE (2018)
Cenegermin, a/k/a recombinant human nerve growth factor
Dompe.
Orphan drug designation for neurotrophic keratitis.

XIIDRA (2016)
Lifitegrast 5%
Shire
Indicated for treatment of signs and symptoms of dry eye disease.

RESTASIS (2003)
Cyclosporine ophthalmioc emulsion 0.05%
Allergan
Indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with KCS.

Other

KLARITY-C
Cyclosporine 0.1% / Chondroitin Sulfate Emulsion
Compounded by Imprimis

Europe

NOVATEARS
Novaliq
Lipid layer stabilizer

OXERVATE (2018) (cenegermin, a/k/a recombinant human nerve growth factor)
Dompe.
Indicated for moderate or severe neurotrophic keratitis.

CACICOL
Corneal matrix repair therapy
Laboratoires Thea
”Intended for management of chronic corneal wound healing, such as PED and persistent corneal dystrophies with associated pain.”

VISOMITIN (Russia)
For moderate to severe dry eye
Mitotech

IKERVIS
Santen’s cyclosporine drug, approved for severe keratitis in dry eye patients for whom artificial tears aren’t enough.

Asia/AU/NZ

DIQUAS (Japan)
Diquafosol sodium 3%
Santen

MUCOSTA (Japan)
Rebamipide ophthalmic suspension 2%
Otsuka Pharmaceutical

NOVATEARS (AU, NZ)
Novaliq
Lipid layer stabilizer